Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Endovascular versus Open Repair of Abdominal Aortic Aneurysm
2010 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Patient decision aid on natural health products for menopausal symptoms: randomized controlled trial
2008
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
Tolerability of sumatriptan: clinical trials and post-marketing experience
2000
Impact of intravascular ultrasound in understanding transplant coronary artery disease
1999
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
1998
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test
2001
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Video decision support tool for advance care planning in dementia: randomised controlled trial
2009
The cost-effectiveness of patient decision aids: A systematic review
2014
An integrative model of shared decision making in medical encounters
2005 Standout
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus
2004
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Decision aids for people facing health treatment or screening decisions
2011
Abdominal aortic aneurysm
2005 Standout
Age and gender bias in statin trials
2001
Decision aids for people facing health treatment or screening decisions
2014
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
2006
Decision aids for people facing health treatment or screening decisions
2003
Effects of Decision Aids for Menorrhagia on Treatment Choices, Health Outcomes, and Costs
2002
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
1994
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The effect of decision aids on the agreement between women’s and physicians’ decisional conflict about hormone replacement therapy
2003
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Where is the theory? Evaluating the theoretical frameworks described in decision support technologies
2008
Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery
2004
Effect of Statins on Risk of Coronary Disease
1999
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Decision aids for people facing health treatment or screening decisions
2009
The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
1998
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
2004
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
1995
Stroke
2008 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
New Insights into Plaque Stabilisation by Lipid Lowering
1998
Diabetes and Atherosclerosis
2002 Standout
Lipid-lowering interventions in angiographic trials
1995
Educational Videos to Reduce Racial Disparities in ICD therapy Via Innovative Designs (VIVID): A randomized clinical trial
2013
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial
2005
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995
Migraine — Current Understanding and Treatment
2002 Standout
Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A Reappraisal
1996
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
2001
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Antiatherothrombotic Properties of Statins
1998
Effect of HMG-CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed Tomography
1998
The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials
1995
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Clinical Decision Support Systems for the Practice of Evidence-based Medicine
2001
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
1995
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Statin-Associated Myopathy
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2007
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
2004
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Impact of Dyslipidemia in End-Stage Renal Disease
2003
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial
2003
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Atherosclerosis
2001 Standout
Range of serum cholesterol values in the population developing coronary artery disease
1995
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
2000
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Effects of Short-Term Treatment of Hyperlipidemia on Coronary Vasodilator Function and Myocardial Perfusion in Regions Having Substantial Impairment of Baseline Dilator Reverse
1998
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Patients or Volunteers? The Impact of Motivation for Trial Participation on the Efficacy of Patient Decision Aids: A Secondary Analysis of a Cochrane Systematic Review
2015
Hyperlipidemia and Coronary Disease
1995
Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients
2008
Patient Decision Aids to Support Clinical Decision Making: Evaluating the Decision or the Outcomes of the Decision
2007
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions
1999
Tolerability of sumatriptan: clinical trials and post-marketing experience
2000
The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis
1999 Standout
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
1998
Decision aids for people facing health treatment or screening decisions
2017 Standout
Drug Discovery: A Historical Perspective
2000 StandoutScience
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Impact of an Educational Video on Patient Decision Making in Early Breast Cancer Treatment
2006
Inflammation and Atherosclerosis
2002 Standout
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis
2000
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors
1999
Inducible Nitric Oxide Synthase Expression in Smooth Muscle Cells and Macrophages of Human Transplant Coronary Artery Disease
1998
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
1995
Progression of Coronary Artery Disease Predicts Clinical Coronary Events
1996
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
1994
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cholesterol Reduction Yields Clinical Benefit
1998
Task force 4. Efficacy of risk factor management
1996
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
1996
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Shared Decision Making — The Pinnacle of Patient-Centered Care
2012 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Cholesterol Reduction Yields Clinical Benefit
1995
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Decision Aids for Benign Prostatic Hyperplasia: Applicability across Race and Education
2004
Works of Peter Gladstone being referenced
Oral sumatriptan-associated transmural myocardial infarction
1995
Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries
1995
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women
1995
Diabetes Atherosclerosis Intervention Study (DAIS): Quantitative coronary angiographic analysis of coronary artery atherosclerosis
1998
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease
2000
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis
1996
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
1994